Liquidia LQDA
NASDAQ LQDA
$68.86 +1.18 (+1.74%)
As of: Sep 9, 2026 · 3:16 PM EDT

Liquidia (LQDA) Other Non-Current Assets (2019 - 2026)

Liquidia (LQDA) posted Other Non-Current Assets of $19.3 million for Q2 2026, up 14.24% on a QoQ basis from $16.9 million in Q1 2026, and down 13.89% year-over-year from $22.4 million in Q2 2025.

Analysis

Liquidia (LQDA) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Liquidia has reported Other Non-Current Assets for 8 years, with the latest figure at $19.3 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets fell 13.89% year-over-year to $19.3 million in Q2 2026; TTM through Jun 2026 was $19.3 million, a 13.89% decrease from a year earlier, with the FY2025 full-year figure at $13.2 million, up 20.64% from the prior year.
  • Other Non-Current Assets was $19.3 million for Q2 2026 at Liquidia, up from $16.9 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $22.4 million in Q2 2025, with the low at $224000.0 in Q1 2024.
  • Average Other Non-Current Assets over 5 years is $6.5 million, with a median of $307000.0 recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slipped 27.04% in 2024, then surged 9908.93% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $307000.0 in 2022, then fell by 6.51% to $287000.0 in 2023, then soared by 3704.18% to $10.9 million in 2024, then gained by 20.64% to $13.2 million in 2025, then soared by 46.57% to $19.3 million in 2026.
  • The last three Other Non-Current Assets figures came in at $19.3 million (Q2 2026), $16.9 million (Q1 2026), and $13.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 14.27 Bn
2 AbbVie 442.18 Bn 435.61 Bn 12.70 Bn 10.73 Bn
3 Merck 366.59 Bn 359.45 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.49 Bn 258.80 Bn 11.24 Bn 5.93 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.34 Bn 44.96 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn - 42.45 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn 239.50 Mn
10 Liquidia 6.12 Bn 5.83 Bn 160.92 Mn 19.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.31 Mn
Mar 31, 2026 16.90 Mn
Dec 31, 2025 13.17 Mn
Sep 30, 2025 8.95 Mn
Jun 30, 2025 22.42 Mn
Mar 31, 2025 15.54 Mn
Dec 31, 2024 10.92 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 224,000.00
Mar 31, 2024 224,000.00
Dec 31, 2023 287,000.00
Sep 30, 2023 287,000.00
Jun 30, 2023 260,000.00
Mar 31, 2023 307,000.00
Dec 31, 2022 307,000.00
Sep 30, 2022 307,000.00
Jun 30, 2022 307,000.00
Mar 31, 2022 307,000.00
Dec 31, 2021 311,000.00
Sep 30, 2021 312,925.00